Create Account
Log In
Dark
chart
exchange
Premium
Terminal
Screener
Stocks
Crypto
Forex
Trends
Depth
Close
Check out our API


Schrdinger to Participate in Five Upcoming Investor Conferences


Business Wire | Nov 22, 2021 08:30AM EST

Schrdinger to Participate in Five Upcoming Investor Conferences

Nov. 22, 2021

NEW YORK--(BUSINESS WIRE)--Nov. 22, 2021--Schrdinger (Nasdaq: SDGR), whose physics-based software platform is transforming the way therapeutics and materials are discovered, today announced that management will participate virtually at the following investor conferences:

* 33rd Annual Piper Sandler Virtual Healthcare Conference: A pre-recorded fireside chat will be available today after 10:00 a.m. ET. * 4th Annual Evercore ISI HealthCONx Conference: Management will participate in a fireside chat on Tuesday, November 30, 2021, at 4:20 p.m. ET. * BMO 2021 Growth & ESG Conference: A fireside chat will take place on Tuesday, December 7th at 1:00 p.m. ET. * Goldman Sachs Byte-ology: The Convergence of Biotechnology and Technology: A Biotech panel will take place on Thursday, December 9, 2021, at 10:00 a.m. ET.

Additionally, the company will participate in one-on-one meetings during the Berenberg Discover AI Seminar 2021 on Wednesday, December 1st.

The live and pre-recorded webcasts can be accessed under "News & Events" in the investors section of Schrdinger's website, https://ir.schrodinger.com/news-and-events/event-calendar and will be archived for approximately seven days.

About Schrdinger

Schrdinger is transforming the way therapeutics and materials are discovered. Schrdinger has pioneered a physics-based software platform that enables discovery of high-quality, novel molecules for drug development and materials applications more rapidly and at lower cost compared to traditional methods. The software platform is used by biopharmaceutical and industrial companies, academic institutions, and government laboratories around the world. Schrdinger's multidisciplinary drug discovery team also leverages the software platform to advance collaborative programs and its own pipeline of novel therapeutics to address unmet medical needs.

Founded in 1990, Schrdinger has over 500 employees and is engaged with customers and collaborators in more than 70 countries. To learn more, visit www.schrodinger.com, our blog www.extrapolations.com, or follow us on LinkedIn and Twitter.

View source version on businesswire.com: https://www.businesswire.com/news/home/20211122005950/en/

CONTACT: Jaren Irene Madden Schrdinger, Inc. jaren.madden@schrodinger.com 617-286-6264

CONTACT: Tracy Lessor Schrdinger, Inc. tracy.lessor@schrodinger.com 617-519-9827






Share
About
Pricing
Policies
Markets
API
Info
tz UTC-4
Connect with us
ChartExchange Email
ChartExchange on Discord
ChartExchange on X
ChartExchange on Reddit
ChartExchange on GitHub
ChartExchange on YouTube
© 2020 - 2026 ChartExchange LLC